Abstract
Obesity is a disease characterized by the excessive accumulation of body fat, which can impair health and lead to metabolic and cardiovascular disorders. In recent years, glucagon-like peptide-1 (GLP-1) analogs have emerged as a promising pharmacological strategy in the fight against obesity. In addition to delaying gastric emptying and reducing food intake, these drugs increase insulin s…